A Randomized Control Study on Effect of 12 Weeks Yoga Therapy in Type 2 Diabetes Mellitus Patients with Distal Polyneuropathy

2017 ◽  
Vol 5 (2) ◽  
pp. 77-82
Author(s):  
Jasmin Parmar ◽  
◽  
Jaydeep D. Kagathara ◽  
Anand H. Mistry ◽  
Vilaschandra J. Patel ◽  
...  
Author(s):  
Vishakha . ◽  
Manish Gupta ◽  
Savita Singh ◽  
Amitesh Aggarwal

Yoga by definition means controlling the modifications of mind. It is also understood as a therapy for health and fitness. Hence, yoga has proved to be of immense help in various lifestyle disorders such as Type 2 Diabetes Mellitus (Type 2 DM). Yoga is also known to reduce stress which is one of the main risk factors in the development of insulin resistance. In this study, we analysed the effect of yoga in known type 2 diabetic patients attending regular medicine Out-Patient Department (OPD) and receiving routine therapy. Research Design and Methods: Setting: Follow-up, randomized control study done in a tertiary care hospital. Participants: 60 Type 2 diabetic patients, between 35-55 years of age, were randomly and equally divided into Group I (yoga) and Group II (controls), age and sex matched. Group II received only routine therapy for DM and Group I underwent yoga therapy along with the routine therapy for 8 weeks. Both groups were assessed twice (pre‑ and post‑study). Statistical Analysis: ANOVA (Repeated measure) followed by Tukey’s test. P < 0.05 was considered significant. Results were expressed as mean ± SD. Results: After 8 weeks of yoga, Group I patients showed a significant improvement in their BMI as shown by reduced body weight. Conclusions: Yoga can be used as an adjunct to the routine treatment for Diabetes Mellitus (DM) as it is not rigorous and so, is far superior than other forms of exercise in comparatively older subjects. Keywords: Type 2 Diabetes Mellitus (Type 2 DM), Body Mass Index (BMI), Yoga, Pranayama.


Author(s):  
Onofre Pineda ◽  
Victoria Stepenka ◽  
Alejandra Rivas-Motenegro ◽  
Nelson Villasmil-Hernandez ◽  
Roberto Añez ◽  
...  

2012 ◽  
Vol 34 (5) ◽  
pp. 795-795
Author(s):  
Star Khoza ◽  
Jamie C. Barner ◽  
Thomas M. Bohman ◽  
Karen Rascati ◽  
Kenneth Lawson ◽  
...  

2015 ◽  
Vol 29 (4) ◽  
pp. 502-507 ◽  
Author(s):  
Yaritza Díaz-Algorri ◽  
María Eugenia Lozada ◽  
Sofía M. López ◽  
Carlos E. Bertrán-Rodríguez ◽  
Cinthia M. González-Hernández ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Young-Gyun Seo ◽  
Ho-Chun Choi ◽  
Ah Reum An ◽  
Do Joon Park ◽  
Young Joo Park ◽  
...  

Aim. The incidence of thyroid cancer is increasing worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is also increasing. Therefore, we aimed to analyze the effect of T2DM on thyroid cancer. Methods. A case-control study was performed. A total of 415 healthy controls with thyroid ultrasound screening and physician consultation were selected from the Thyroid Cancer Longitudinal Study (T-CALOS). Among patients with thyroid cancer who were enrolled in T-CALOS, 415 patients were matched to the control group according to age and sex. We assessed the effects of T2DM, T2DM duration, and T2DM medication on thyroid cancer. Results. Women with T2DM had lower odds of thyroid cancer than women without T2DM (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.20–0.81). Individuals receiving T2DM medication had higher odds of thyroid cancer compared to those without T2DM medication (OR: 5.21, 95% CI: 1.58–17.15). Individuals with T2DM duration <6 years had lower odds of thyroid cancer compared to those without T2DM (OR: 0.58, 95% CI: 0.34–0.97). Conclusions. Individuals with early T2DM are presumed to have a low incidence of thyroid cancer, and this effect seems to last up to 6 years after diagnosis of T2DM.


Sign in / Sign up

Export Citation Format

Share Document